As of 2026-01-02, the Intrinsic Value of Atea Pharmaceuticals Inc (AVIR) is -47.05 USD. This Atea valuation is based on the model Peter Lynch Fair Value. With the current market price of 3.57 USD, the upside of Atea Pharmaceuticals Inc is -1,417.79%.
Based on its market price of 3.57 USD and our intrinsic valuation, Atea Pharmaceuticals Inc (AVIR) is overvalued by 1,417.79%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -47.05 - -47.05 | -47.05 | -1,417.79% |
| P/E | (35.30) - (37.67) | (36.84) | -1131.8% |
| DDM - Stable | (12.21) - (41.68) | (26.95) | -854.9% |
| DDM - Multi | (12.59) - (34.59) | (18.59) | -620.9% |
| Market Cap (mil) | 278.92 |
| Beta | 0.40 |
| Outstanding shares (mil) | 78.13 |
| Enterprise Value (mil) | 201.58 |
| Market risk premium | 4.60% |
| Cost of Equity | 11.42% |
| Cost of Debt | 5.00% |
| WACC | 8.18% |